These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8030291)

  • 1. [The Depo-Provera treatment of mastopathy patients].
    Khomasuridze AG; Manusharova RA
    Lik Sprava; 1993; (10-12):104-6. PubMed ID: 8030291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen in women with menstrual disturbances and fibrocystic mastopathy.
    Radowicki S; Kunicki M
    J Endocrinol Invest; 2009 Nov; 32(10):821-4. PubMed ID: 19602918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal correlations in uterine myoma, internal endometriosis and diffuse mastopathy in patients with a retained biphasic menstrual cycle].
    Sokolova ZP
    Akush Ginekol (Mosk); 1982 Jun; (6):15-9. PubMed ID: 6812446
    [No Abstract]   [Full Text] [Related]  

  • 4. [The steroid and peptide hormone content of the blood in women with different forms of fibrocystic mastopathy].
    Serov VN; Tumilovich LG; Rozhkova NI; Samoĭlova TE
    Akush Ginekol (Mosk); 1988 Mar; (3):54-6. PubMed ID: 3400830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of long-acting contraceptives in the treatment of mastopathy].
    Khomasuridze AG; Manusharova RA; Marsagishvili NG
    Probl Endokrinol (Mosk); 1994; 40(5):29-30. PubMed ID: 7899437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of mastopathy with cyclic mastodynia: clinical results and hormone profile].
    Kubista E; Müller G; Spona J
    Gynakol Rundsch; 1986; 26(2):65-79. PubMed ID: 3525344
    [No Abstract]   [Full Text] [Related]  

  • 7. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
    Murta EF; de Freitas MM; Velludo MA
    Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mastopathy and breast cancer: is there a typical hormone profile?].
    Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC; Sellwood RA; Knyba RE; Irvine JD
    Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endocrine markers in benign breast diseases].
    Thalabard JC; Sitruk-Ware R; Kuttenn F; Mauvais-Jarvis P
    Zentralbl Gynakol; 1986; 108(6):354-8. PubMed ID: 3716674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys.
    Hild-Petito S; Veazey RS; Larner JM; Reel JR; Blye RP
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S125-30. PubMed ID: 9581896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of selected hormonal parameters in patients with mastopathy in postmenopausal period].
    Mizia-Stec K; Zych F; Widala E
    Ginekol Pol; 1998 Feb; 69(2):56-61. PubMed ID: 9591381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolactin and luteal phase defect (author's transl)].
    Mühlenstedt D; Meissner M; Schneider HP
    Geburtshilfe Frauenheilkd; 1979 Jul; 39(7):580-7. PubMed ID: 467952
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy].
    Ablanedo J; Canales ES
    Arch Invest Med (Mex); 1988; 19(3):225-9. PubMed ID: 3242433
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conservative therapy of mastopathy].
    Kubista E; Müller G; Spona J
    Zentralbl Gynakol; 1983; 105(18):1153-62. PubMed ID: 6685418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with danazol treatment of endometriosis and mastopathy].
    Pavelka R; Schneider WH
    Wien Klin Wochenschr; 1981 Oct; 93(19):595-9. PubMed ID: 6798763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS; Dennerstein GJ
    Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depo-provera: clinical evaluation.
    Mukherjea M
    Contracept Deliv Syst; 1981 Jul; 2(3):259-69. PubMed ID: 12278913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dealing with Depo: you can manage bleeding with estrogen, ibuprofen.
    Contracept Technol Update; 1995 Dec; 16(12):145-8. PubMed ID: 12347032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.